| Subspecialty | Pulmonary Disease |
|---|---|
| Clinical Interests | Critical Care |
| Gender | Male |
| david.nierman@mountsinai.org | |
| Education and Training | MD, Sackler Fac. of Med., Tel Aviv Un. |
| Residency, Internal Medicine, Long Island Jewish Medical Center | |
| Fellowship, Pulmonary, St. Luke's-Roosevelt Hospital Ctr. |
| Education and Training | MD, Sackler Fac. of Med., Tel Aviv Un. |
|---|---|
| Residency, Internal Medicine, Long Island Jewish Medical Center | |
| Fellowship, Pulmonary, St. Luke's-Roosevelt Hospital Ctr. | |
| Board Certification | Pulmonary Disease |
| Subspecialty | Pulmonary Disease |
|---|---|
| Clinical Interests | Critical Care |
| Board Certification | Pulmonary Disease |
The Chronically Critically Ill
Most patients admitted to intensive care units either recover or die within the first few days of the onset of critical illness. However, a subgroup of critically ill patients enters a more prolonged phase with a continuing need for mechanical ventilation and intensive nursing care that may last for weeks to months. These patients have been termed the chronically critically ill. My main research interest is devoted to improving the outcomes of these patients.
Current clinical studies include:
In addition, the Medical ICU is an active participant in national and international multi-center trials in acute critical illness. Ongoing studies include:
Nelson JE, Meier DE, Oei EJ, Nierman D, Senzel RS, Manfredi PL, Davis SM, Morrison RS. Self-reported symptom experience of critically ill cancer patients receiving intensive care. Crit Care Med 2001 Feb; 29(2): 277-82.
Discover how The Mount Sinai Medical Center can offer you the most advanced and compassionate inpatient and outpatient care.
The Mount Sinai Medical Center is home to an extensive array of top-notch research centers and laboratories, where scientists and researchers work to translate the rapid advances in basic science into the innovative patient care for which we are known.
Participating in Mount Sinai’s clinical trials allows you to take advantage of innovative treatments as we work together to advance the future of medicine.
